Crinetics Pharmaceuticals Inc (CRNX)

Crinetics Pharmaceuticals Inc (CRNX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Sep 2, 2026: market cap $9B; returns 1 week +0.1%, 1 year +155.1%.

Crinetics Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel oral small-molecule therapeutics targeting endocrine diseases and endocrine-related tumors. The company's core expertise lies in targeting G-protein coupled receptors (GPCRs), a class of cell surface proteins involved in various physiological processes and diseases.

CRNX financial model: income statement, cash flow and balance sheet